Diphenhydramine

What is Diphenhydramine?

Diphenhydramine is a first-generation antihistamine that has been used for decades as a short-term aid for occasional sleeplessness. It is available without a prescription (over the counter) in many EU countries under brand names such as Nytol, Sominex, and Benadryl Night. It is one of the most widely used OTC sleep aids globally.

While diphenhydramine is accessible without a prescription, this does not mean it is without risk. It carries a meaningful side effect profile, particularly for older adults, and is not appropriate for everyone or for long-term use.

How does Diphenhydramine work?

Diphenhydramine exerts its sedating effect by blocking histamine H1 receptors in the central nervous system. Histamine is a neurotransmitter involved in maintaining wakefulness. By blocking histamine signalling in the brain, diphenhydramine suppresses alertness and induces sedation.

In addition to its antihistamine action, diphenhydramine also has anticholinergic properties — it blocks acetylcholine receptors throughout the body. This anticholinergic activity is responsible for many of its common side effects, including dry mouth, blurred vision, urinary retention, and constipation.

A key pharmacological limitation is that tolerance to diphenhydramine’s sedating effects develops rapidly, often within two to three nights of consecutive use, reducing its effectiveness as a sleep aid with repeated dosing.

Who is Diphenhydramine for?

Diphenhydramine may be appropriate for adults who experience occasional, short-term sleeplessness — for example, during periods of stress, travel, or temporary disruption to sleep patterns. It is not intended as a treatment for chronic insomnia or sleep disorders with identifiable underlying causes.

It is not appropriate for:

• Children under 12 years of age (risk of serious adverse effects)
• Older adults (significantly increased risk of confusion, falls, and anticholinergic effects)
• People with glaucoma, urinary retention, or enlarged prostate
• People with severe cardiovascular disease
• People taking other sedating medicines, including alcohol

Anyone with persistent sleep problems — typically defined as difficulty sleeping more than three nights per week over a period of more than four weeks — should consult a doctor for proper evaluation.

Dosage

The standard adult dose of diphenhydramine for sleep is 25 mg to 50 mg, taken orally approximately 30 minutes before bedtime. Most OTC formulations come in 25 mg or 50 mg tablets.

Parameter	Guidance
Typical adult dose	25–50 mg
Timing	30 minutes before bedtime
Maximum duration	2 weeks (short-term use only)
Minimum sleep time	At least 8 hours available

Patients should not take more than the recommended dose. Diphenhydramine should not be used for more than two consecutive weeks without medical supervision.

Side effects

Common side effects

• Next-day drowsiness: Due to its long half-life (~9 hours), sedation may persist significantly into the following day, impairing driving and cognitive function
• Dry mouth
• Blurred vision
• Constipation
• Urinary retention: Particularly in men with enlarged prostate

Less common but serious effects

• Confusion and disorientation: Particularly in older adults; diphenhydramine is listed on the Beers Criteria as a medication to avoid in adults over 65
• Paradoxical excitation: Some individuals, particularly children, experience stimulation rather than sedation
• Urinary retention requiring catheterisation
• Anticholinergic toxicity in overdose: Characterised by rapid heart rate, high temperature, agitation, and hallucinations

Tolerance and dependence

Diphenhydramine does not carry the same dependence risk as benzodiazepines or Z-drugs. However, psychological reliance on OTC sleep aids can develop, and the rapid development of tolerance means its effectiveness diminishes quickly with nightly use.

Diphenhydramine vs alternatives

Medicine	Type	Prescription Required	Dependence Risk	Best For
Diphenhydramine	OTC antihistamine	No	Low	Occasional short-term sleep difficulty
Melatonin	Hormone supplement	No (low dose)	Minimal	Circadian rhythm disruption, jet lag
Zopiclone	Z-drug hypnotic	Yes	Moderate	Short-term clinical insomnia
Zolpidem	Z-drug hypnotic	Yes	Moderate	Short-term sleep onset difficulty
Lormetazepam	Benzodiazepine	Yes	Higher	Severe, treatment-resistant insomnia

The choice between these options depends on the severity, duration, and cause of sleep difficulties, as well as individual patient factors. A doctor is best placed to advise on which approach is appropriate.

How to access sleep treatment online in Europe

For OTC sleep aids such as diphenhydramine, a prescription is not required in most EU countries. However, if your sleep difficulties are persistent, severe, or impacting your quality of life, it is important to consult a healthcare professional rather than self-managing with OTC products indefinitely.

Prescrivia operates as a technology intermediary that connects patients with independent EU-registered doctors for online health assessments. Our platform does not prescribe medicines, employ doctors, or sell medicines directly. If a doctor determines that a prescription sleep treatment is clinically appropriate, they may issue a prescription, which is then fulfilled by a licensed EU pharmacy partner.

Important: Prescrivia does not guarantee that a prescription will be issued. All clinical decisions are made independently by qualified medical professionals.

Important safety information

Do not take Diphenhydramine if you:

• Are under 12 years old
• Are pregnant or breastfeeding
• Have glaucoma, urinary retention, or prostate enlargement
• Are taking other antihistamines, sedatives, or tranquilisers

Exercise caution if you:

• Are over 65 years of age
• Need to drive or operate machinery the following day
• Have liver or kidney impairment

Drug interactions: Diphenhydramine interacts with alcohol (enhanced sedation), other antihistamines, benzodiazepines, opioids, antidepressants (particularly MAOIs and tricyclics), and anticholinergic medicines. Always disclose all medications to your pharmacist or doctor.

Sources

Medical information on this page is based on the following sources:

• European Medicines Agency (EMA). Guideline on the clinical investigation of medicinal products for the treatment of insomnia. EMA/CHMP/16274/2009.
• World Health Organization (WHO). Sleep disorders — Fact sheet. who.int
• American Geriatrics Society. Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. 2023 Update.

This content is reviewed periodically to reflect updated clinical guidance. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.